Retour à l'accueil - Logo OERECA

EA 2608 | Oestrogènes, reproduction, cancer

Accueil > Publications et diffusion scientifique > 2016


2016

Dig1 protects against locomotor and biochemical dysfunctions provoked by Roundup.
Gress S, Laurant C, Defarge N, Travert C, Séralini GÉ.
BMC Complement Altern Med. 2016 Jul 22;16:234. doi: 10.1186/s12906-016-1226-6.

Differential effects of bisphenol A and estradiol on rat spermatogenesis' establishment.
Brouard V, Guénon I, Bouraima-Lelong H, Delalande C.
Reprod Toxicol. 2016 Aug;63:49-61. doi: 10.1016/j.reprotox.2016.05.003. Epub 2016 May 9.

Co-Formulants in Glyphosate-Based Herbicides Disrupt Aromatase Activity in Human Cells below Toxic Levels.
Defarge N, Takács E, Lozano VL, Mesnage R, Spiroux de Vendômois J, Séralini GE, Székács A.
Int J Environ Res Public Health. 2016 Feb 26;13(3). pii: E264. doi: 10.3390/ijerph13030264.

Implication of the estrogen receptors GPER, ESR1, ESR2 in post-testicular maturations of equine spermatozoa.
Gautier C, Barrier-Battut I, Guénon I, Goux D, Delalande C, Bouraïma-Lelong H.
Gen Comp Endocrinol. 2016 Jul 1;233:100-8. doi: 10.1016/j.ygcen.2016.05.022. Epub 2016 May 21.

SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Reznik Y, Amar L, Tabarin A.
Ann Endocrinol (Paris). 2016 Jul;77(3):202-7. doi: 10.1016/j.ando.2016.01.007. Epub 2016 Jun 16.

SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L, Baguet JP, Bardet S, Chaffanjon P, Chamontin B, Douillard C, Durieux P, Girerd X, Gosse P, Hernigou A, Herpin D, Houillier P, Jeunemaitre X, Joffre F, Kraimps JL, Lefebvre H, Ménégaux F, Mounier-Véhier C, Nussberger J, Pagny JY, Pechère A, Plouin PF, Reznik Y, Steichen O, Tabarin A, Zennaro MC, Zinzindohoue F, Chabre O.
Ann Endocrinol (Paris). 2016 Jul;77(3):179-86. doi: 10.1016/j.ando.2016.05.001. Epub 2016 Jun 15.

Therapeutic innovations in endocrine diseases - Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?
Reznik Y.
Presse Med. 2016 Jun;45(6 Pt 2):e205-10. doi: 10.1016/j.lpm.2016.05.007. Epub 2016 May 31. Review.

Sustained Efficacy of Insulin Pump Therapy in Type 2 Diabetes: 9-Year Follow-up in a Cohort of 161 Patients.
Morera J, Joubert M, Morello R, Rod A, Lireux B, Reznik Y.
Diabetes Care. 2016 Jun;39(6):e74-5. doi: 10.2337/dc16-0287. Epub 2016 Apr 8. No abstract available.

Response to Letter to the Editor Regarding OpT2mise Study.
Conget I, Aronson R, Cohen O, Reznik Y.
Diabetes Technol Ther. 2016 Jul;18(7):448. doi: 10.1089/dia.2016.0081. Epub 2016 Apr 4. No abstract available.

Deletion of CPEB1 Gene: A Rare but Recurrent Cause of Premature Ovarian Insufficiency.
Hyon C, Mansour-Hendili L, Chantot-Bastaraud S, Donadille B, Kerlan V, Dodé C, Jonard S, Delemer B, Gompel A, Reznik Y, Touraine P, Siffroi JP, Christin-Maitre S.
J Clin Endocrinol Metab. 2016 May;101(5):2099-104. doi: 10.1210/jc.2016-1291. Epub 2016 Mar 22.

Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands.
Roze S, Duteil E, Smith-Palmer J, de Portu S, Valentine W, de Brouwer BF, Reznik Y, de Valk HW.
J Med Econ. 2016 Aug;19(8):742-9. doi: 10.3111/13696998.2016.1167695. Epub 2016 Apr 5.

Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.
Picard S, Hanaire H, Baillot-Rudoni S, Gilbert-Bonnemaison E, Not D, Reznik Y, Guerci B.
Diabetes Technol Ther. 2016 Mar;18(3):127-35. doi: 10.1089/dia.2015.0240. Epub 2016 Mar 7.

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.
Aronson R, Reznik Y, Conget I, Castañeda JA, Runzis S, Lee SW, Cohen O; OpT2mise Study Group.
Diabetes Obes Metab. 2016 May;18(5):500-7. doi: 10.1111/dom.12642. Epub 2016 Mar 22.

X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome.
Fiot E, Zenaty D, Boizeau P, Haigneré J, Dos Santos S, Léger J; French Turner Syndrome Study Group.
Eur J Endocrinol. 2016 Mar;174(3):281-8. doi: 10.1530/EJE-15-1000. Epub 2015 Dec 14.


Télécharger la page

Dernière modification : 24 juillet 2017



Université de Caen Normandie
Laboratoire OERECA
Esplanade de la Paix | CS 14032 | 14032 CAEN cedex 5